Search

Apply now: BioMarin Golden Ticket—$50K lab credit to LabCentral >

Search

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma

Science Exchange Signs on as LabCentral Sponsor to Support Life Science and Biotech Startups with Outsourced R&D Services

Read More

Stealthy Flagship cancer drug startup nabs $21M, new Kendall Square digs

Agilent Technologies Joins with LabCentral to Help Advance Scientific Discovery

Read More

LabCentral to Open Next-Stage Facility for Growing Life-Science Companies, Supported by Pfizer

In December 2017, LabCentral plans to open…

Read More

Amgen And LabCentral Open Nomination Process For Lab Residency

LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy 25th Anniversary Congress in Berlin

Baker-Polito Administration Awards $11.9 Million in Workforce Training Fund Grants

Unum Therapeutics to Present New Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Vedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live Biotherapeutics that Induce CD8+ T Cells